Euroopan unioni - norja - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hydrochloride - multippel sklerose, relapsing-remitting - immunsuppressive - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1)orpatients med raskt utviklende alvorlig relapsing remitting multippel sklerose definert ved 2 eller flere deaktivere tilbakefall i ett år, og med 1 eller flere gadolinium å styrke lesjoner på brain mr eller en betydelig økning i t2 lesjon legg i forhold til en tidligere nyere mr.

Norja - norja - Statens legemiddelverk

2care4 generics aps - merkaptopurin - tablett - 50 mg

Euroopan unioni - norja - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hydrochloride - multippel sklerose, relapsing-remitting - immunsuppressive - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Norja - norja - Statens legemiddelverk

teva gmbh - fingolimodhydroklorid - kapsel, hard - 0.5 mg

Norja - norja - Statens legemiddelverk

tillomed pharma gmbh - schönefeld - fingolimodhydroklorid - kapsel, hard - 0.5 mg

Euroopan unioni - norja - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunsuppressive - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.

Norja - norja - Statens legemiddelverk

galderma nordic ab - klobetasolpropionat - sjampo - 500 mikrog/ g

Norja - norja - Statens legemiddelverk

glaxosmithkline as - klobetasolpropionat - krem - 0.05 %

Norja - norja - Statens legemiddelverk

glaxosmithkline as - klobetasolpropionat - liniment, oppløsning - 0.5 mg/ ml

Norja - norja - Statens legemiddelverk

glaxosmithkline as - klobetasolpropionat - salve - 0.05 %